Percutaneous tumor ablation: Reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model

Radiology

Volumn 228, Issue 1, 2003, Pages 112-118

  D'Ippolito, Giuseppe ^a   Ahmed, Muneeb ^a   Girnun, Geoffrey D ^a   Stuart, Keith E ^a   Kruskal, Jonathan B ^a   Halpern, Elkan F ^b   Goldberg, S Nahum ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adenocarcinoma; Animals; Breast neoplasms, experimental studies; Chemotherapy; Experimental study; Radiofrequency (RF) ablation

Indexed keywords

DOXORUBICIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST TUMOR; CATHETER ABLATION; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; GROWTH RATE; HISTOPATHOLOGY; INTERVENTIONAL RADIOLOGY; NONHUMAN; PERCUTANEOUS TUMOR ABLATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RAT; SURVIVAL; TUMOR GROWTH; TUMOR MODEL;

ANIMALS; ANTINEOPLASTIC AGENTS; CATHETER ABLATION; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; INJECTIONS, INTRAVENOUS; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344;

EID: 0038376198     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2281020358     Document Type: Article

References (42)

1. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174:323-331.
2. Dodd GD III, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. RadioGraphics 2000; 20:9-27.
3. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000; 217:633-646.
4. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998; 170:1015-1022.
5. Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radiofrequency ablation with cooled-tip electrodes. Radiology 1997; 205:367-373.
6. de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 2000; 175:1619-1625.
7. Livraghi T, Lazzaroni S, Meloni F. Radiofrequency thermal ablation of hepatocellular carcinoma. Eur J Ultrasound 2001; 13:159-166.
8. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001; 6:14-23.
9. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761-768.
10. Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217:665-672.
11. Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002; 167:10-15.
12. Dupuy DE, Zagoria RJ, Akerley W, MayoSmith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174:57-59.
13. Abraham J, Foio T, Wood BJ. Radiofrequency ablation of metastatic lesions in adrenocortical cancer. Ann Intern Med 2000; 133:312-313.
14. Wood BJ, Bates S. Radiofrequency thermal ablation of a splenic metastasis. J Vasc Interv Radiol 2001; 12:261-263.
15. Rosenthal DI, Hornicek FJ, Wolfe MW, Jennings LC, Gebhardt MC, Mankin HJ. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am 1998; 80:815-821.
16. Lindner NJ, Ozaki T, Roedl R, Gosheger G, Winkelmann W, Wortler K. Percutaneous radiofrequency ablation in osteoid osteoma. J Bone Joint Surg Br 2001; 83:391-396.
17. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: Challenges and opportunities. II. J Vasc Interv Radiol 2001; 12:1135-1148.
18. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655-661.
19. Chopra S, Dodd GD III, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol 2001; 177:381-387.
20. Siperstein A, Garland A, Engle K, et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 2000; 7:106-113.
21. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221:159-166.
22. Goldberg SN, Kruskal JB, Oliver BS, Clouse ME, Gazelle GS. Percutaneous tumor ablation: increased coagulation by combining radio-frequency ablation and ethanol instillation in a rat breast tumor model. Radiology 2000; 217:827-831.
23. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217:119-126.
24. Goldberg SN, Girnun GD, Lukyanov AN, et al. Percutaneous tumor ablation: Increased necrosis with combined radiofrequency and intravenous doxorubicin in a liposome carrier in a rat breast tumor model. Radiology 2002; 222:797-804.
25. Monsky WL, Kruskal JB, Lukyanov AN, et al. Radiodrequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology 2002; 224:823-829.
26. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979; 39:2264-2268.
27. Wallah DFG. Basic mechanism in tumor thermotherapy. J Mol Med 1977; 17:381-403.
28. Goldberg SN, Kamel IR, Kruskal JB, et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol 2002; 179:93-101.
29. Less JR, Skalak TC, Sevick EM, Jain RK. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 1991; 51:265-273.
30. Altman DG, Bland JM. How to randomise. BMJ 1999; 319:703-704.
31. Wallace J. Humane endpoints and cancer research. Inst Lab Animal Res J 2000; 41:87-93.
32. Shaheen RM, Tseng WW, Davis DW, et al. Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res 2001; 61:1464-1468.
33. Goldberg SN, Saldinger PF, Gazelle GS, et al. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model. Radiology 2001; 220:420-427.
34. Tannock IF. Cell proliferation. In: Tannock IF, Hill RP, eds. The basic science of oncology. 2nd ed. McGraw-Hill: New York, NY, 1992; 154-156.
35. Izumi N, Asahina Y, Noguchi O, et al. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001; 91:949-956.
36. Buscarini L, Buscarini E. Therapy of HCCradiofrequency ablation. Hepatogastroenterology 2001; 48:15-19.
37. Kruskal JB, Oliver B, Huertas JC, Goldberg SN. Dynamic intrahepatic flow and cellular alterations during radiofrequency ablation of liver tissue in mice. J Vasc Interv Radiol 2001; 12:1193-1201.
38. Kokura S, Yoshikawa T, Kaneko T, et al. Efficacy of hyperthermia and polyunsaturated fatty acids on experimental carcinoma. Cancer Res 1997; 57:2200-2202.
39. Yoshikawa T, Kokura S, Tainaka K. Efficacy of hyperthermia and polyunsaturated fatty acids on experimental carcinoma. Cancer Res 1997; 53:2326-2329.
40. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities. I. J Vasc lnterv Radiol 2001; 12:1020-1032.
41. de Baere T, Denys A, Wood BJ, et al. Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. AJR Am J Roentgenol 2001; 176:187-192.
42. Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000; 43:656-661.